Intracerebral metastases differential diagnosis

	Intracerebral metastases Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Intracerebral Metastases from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Intracerebral metastases differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Intracerebral metastases differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Intracerebral metastases differential diagnosis
CDC on Intracerebral metastases differential diagnosis
Intracerebral metastases differential diagnosis in the news
Blogs on Intracerebral metastases differential diagnosis
Directions to Hospitals Treating Intracerebral metastases
Risk calculators and risk factors for Intracerebral metastases differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Intracranial metastases must be differentiated from:

Abscess: typically hypermetabolic with central hypometabolism signifying necrosis
CVA
Primary brain neoplasm
Meningioma
Post-treatment effects (post-surgical or post radiation): hypermetabolic acutely progressing to hypometabolic over time
Epilepsy